Effects of a consumer driven health plan on pharmaceutical spending and utilization

Health Services Research

Volumn 43, Issue 5 P1, 2008, Pages 1542-1556

  Parente, Stephen T ^a,b   Feldman, Roger ^a   Chen, Song ^c  

^a Department of Finance ^*

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Consumer driven health plans; Health insurance; Pharmaceutical cost and use

Indexed keywords

GENERIC DRUG;

ARTICLE; COHORT ANALYSIS; CONSUMER ATTITUDE; COST CONTROL; DRUG INDUSTRY; EMPLOYER; GROUPS BY AGE; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH STATUS; HUMAN; INCOME; INSURANCE; PHARMACY; REGRESSION ANALYSIS; SEX DIFFERENCE;

ADULT; AGE FACTORS; CHRONIC DISEASE; COST SHARING; DRUG UTILIZATION; DRUGS, GENERIC; FEES, PHARMACEUTICAL; FEMALE; HEALTH BENEFIT PLANS, EMPLOYEE; HEALTH EXPENDITURES; HUMANS; INCOME; INSURANCE CLAIM REVIEW; MALE; MEDICAL SAVINGS ACCOUNTS; POSTAL SERVICE; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 52149089425     PISSN: 00179124     EISSN: 14756773     Source Type: Journal    
DOI: 10.1111/j.1475-6773.2008.00857.x     Document Type: Article

References (13)

1. Curtiss, F. R. 2002 Perspectives: Drugs, PPOs, Tiered Cost Share for Beneficiaries and Consumer Preferences Journal of Managed Care Pharmacy 8 : 177 80.
2. Feldman, R. S. T. Parente. 2007 Enrollee Incentives in Consumer Directed Health Plans." Presented at the 6th World Congress of the International Health Economics Organization, Copenhagen, Denmark, July 9.
3. Feldman, R., S. T. Parente J. Christianson. 2007 Consumer Directed Health Plans: New Evidence on Cost & Utilization Inquiry 44 (1) : 26 40.
4. Gibson, T. B., R. J. Ozminkowski R. Z. Goetzel. 2005 The Effects of Prescription Drug Cost Sharing: A Review of the Evidence American Journal of Managed Care 11 : 730 740.
5. Huskamp, H. A., P. A. Deverka, A. M. Epstein, et al. 2005 Impact of 3-tier Formularies on Drug Treatment of Attention-Deficit/Hyperactivity Disorder in Children Archive of General Psychiatry 62 : 435 41.
6. Kaiser Family Foundation and the Health Research and Education Trust. 2004 Employer Health Benefits 2004 Annual Report"[accessed on April 16, 2006]. Available at.
7. Nair, K. V., P. Wolfe, R. J. Valuck, M. M. McCollum, J. M. Ganther S. J. Lewis. 2003 Effects of a 3-tier Pharmacy Benefit Design on The Prescription Purchasing Behavior of Individuals with Chronic Disease Journal of Managed Care Pharmacy 9 : 123 33.
8. Parente, S. T., R. Feldman J. B. Christianson. 2004 Evaluation of the Effect of a Consumer-Driven Health Plan on Medical Care Expenditures and Utilization Health Services Research 39 : 1189 210.
9. Pauly, M. V. 1968 The Economics of Moral Hazard: Comment American Economic Review 58 : 531 537.
10. Rector, T. S., M. D. Finch, P. M. Danzon, M. V. Pauly B. S. Manda. 2003 Effect of Tiered Prescription Copayments on the Use of Preferred Brand Medications Medical Care 41 : 398 406.
11. Schneeweiss, S., M. Maclure, A. M. Walker, P. Grootendorst S. B. Soumerai. 2001 On the Evaluation of Drug Benefits Policy Changes with Longitudinal Claims Data: The Policy Maker's versus the Clinician's Perspective Health Policy 55 : 97 109.
12. Tamblyn, R., R. Laprise, J. A. Hanley, et al. 2001 Adverse Events Associated with Prescription Drug Cost-Sharing Among Poor And Elderly Persons Journal of the American Medical Association 285 : 421 9.
13. Weiner, J. P., B. H. Starfield, D. M. Steinwachs L. M. Mumford Development and Application of a Population-oriented Measure of Ambulatory Care Case-Mix Medical Care 1991 29 : 452 72.